ClinicalTrials.gg

Program

TAK-003

A development code. Also written as “TDV” and “Tetravalent Dengue Vaccine (TDV)”.

Its studies are mostly in Dengue, led by Takeda.

Furthest: phase 3, since Jan 31, 20186 company-led studies, 3 open or runningNext primary completion: Apr 14, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Takeda63 open or runningphase 3since Jan 31, 2018Jan 31, 2018Apr 14, 2027phase 3 · NCT06579755

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 31, 2018First study: phase 3 study in DengueFirst studyNCT03423173 · 923 enrolled · United States
  2. Sep 22, 2023Phase 3 study in Healthy VolunteersNCT06060067 · 480 enrolled · India
  3. Aug 29, 2024Phase 3 study in DengueNCT06579755 · 800 enrolled · Argentina, Brazil, Singapore and more
  4. Oct 29, 2024Phase 3 study in DengueNCT06665035 · 212 planned · Colombia, Thailand
  5. Dec 15, 2024Phase 3 study in DengueNCT06741683 · 187 enrolled · Japan
  6. Jun 24, 2025Phase 3 study in DengueNCT07047521 · 496 enrolled · Australia

Ahead

  1. Apr 14, 2027Primary completion: phase 3 study in DengueNCT06579755
  2. Mar 3, 2030Primary completion: phase 3 study in DengueNCT06665035

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07047521Dengue · Australia3Active, not recruitingJun 29, 2026496
NCT06741683Dengue · Japan3CompletedJul 9, 2025187
NCT06665035Dengue · Colombia, Thailand3RecruitingMar 3, 2030212
NCT06579755Dengue · Argentina, Brazil, Singapore and more3Active, not recruitingApr 14, 2027800
NCT06060067Healthy Volunteers · India3CompletedMay 5, 2025480
NCT03423173Dengue · United States3CompletedAug 3, 2018923

How it is read

Names in the registry

  • “TDV”, 4 entries
  • “Tetravalent Dengue Vaccine (TDV)”, 1 entry
  • “TAK-003”, 1 entry

Codes read as this program: TAK003.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.